Page last updated: 2024-08-04 07:48:34

callipeltoside a

Description

callipeltoside A: isolated from the sponge Callipelta; structure in first source [MeSH]

Cross-References

ID SourceID
PubMed CID165365515
MeSH IDM0365557

Synonyms (3)

Synonym
183671-13-8
callipeltoside a
DTXSID401043926

Research

Studies (21)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (4.76)18.2507
2000's15 (71.43)29.6817
2010's5 (23.81)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (9.52%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (90.48%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
hydrobromic acidgas molecular entity;
hydrogen halide;
mononuclear parent hydride
mouse metabolite2000200024.0low001000
1-anilino-8-naphthalenesulfonateaminonaphthalene;
naphthalenesulfonic acid
fluorescent probe2000200024.0low001000
mannitolmannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
2001200123.0low000100
threonineamino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine
algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
2001200123.0low000100
3-hydroxybutanal2011201113.0low000010
keteneketene2008200816.0low000100
palladiummetal allergen;
nickel group element atom;
platinum group metal atom
2000200024.0low001000
chromiumchromium group element atom;
metal allergen
micronutrient2003200321.0low000100
goldcopper group element atom;
elemental gold
2012201212.0low000010
rhamnoseL-rhamnose2002200222.0low000100
lyngbyaloside b2008200816.0high000100
glycosides2003200818.5medium000200
macquarimicin a2011201113.0high000010
lyngbouilloside2003200321.0high000100
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Cancer of Ovary02002200222.0high000100
Ovarian Neoplasms02002200222.0high000100